OncoMethylome, Ciphergen, Clinical Data, Proteome Sciences, Agilent, Cogenics | GenomeWeb

OncoMethylome Raises €3.3M, Bringing IPO Proceeds up to €25.3M

Following its initial public offering and Euronext listing on June 27, OncoMethylome Sciences said last week that it has raised an additional €3.3 million ($4.2 million) through the exercise of over-allotment option by Fortis and ING, the joint lead managers in the offering.

OncoMethylome granted the option on up to 440,000 new shares, at the IPO price of €7.5 ($9.5) per share.

As a result, the company's proceeds from the IPO total €25.3 million ($32.2 million).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.